L-type calcium channel — Drug Target
All drugs that target L-type calcium channel — marketed and clinical-stage. Includes 5 drug classes acting on this target.
Drug classes
Dihydropyridine calcium channel blocker · Calcium channel blocker (non-dihydropyridine) · Non-dihydropyridine calcium channel blocker · Calcium channel blocker (dihydropyridine) · calcium channel blocker
Marketed (8)
- Amlodipine camsylate · Organon and Co · Dihydropyridine calcium channel blocker · Cardiovascular
Amlodipine camsylate blocks L-type calcium channels in vascular smooth muscle and cardiac tissue, reducing calcium influx and causing vasodilation and decreased blood pressure. - Verapamil Injection · Nishtar Medical University · Calcium channel blocker (non-dihydropyridine) · Cardiovascular
Verapamil blocks L-type calcium channels in cardiac and vascular smooth muscle, reducing calcium influx and slowing electrical conduction. - Nifedipine (Adalat, BAYA1040) · Bayer · Dihydropyridine calcium channel blocker · Cardiovascular
Nifedipine blocks L-type calcium channels in vascular smooth muscle and cardiac tissue, reducing calcium influx and causing vasodilation and decreased cardiac contractility. - Cleviprex® · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Dihydropyridine calcium channel blocker · Cardiovascular
Cleviprex is a dihydropyridine calcium channel blocker that selectively inhibits L-type calcium channels in vascular smooth muscle, causing vasodilation and reducing blood pressure. - Verapamil HEXAL (verapamil) · Zealand University Hospital · Calcium channel blocker (non-dihydropyridine) · Cardiovascular
Verapamil blocks L-type calcium channels in cardiac and vascular smooth muscle, reducing calcium influx and decreasing heart rate, contractility, and blood pressure. - Diltiazem treated group · Seoul National University Hospital · Non-dihydropyridine calcium channel blocker · Cardiovascular
Diltiazem blocks L-type calcium channels in cardiac and vascular smooth muscle, reducing calcium influx and decreasing heart rate and blood pressure. - Nifedipine GITS (Adalat® XL 30 · Shanghai Jiao Tong University School of Medicine · Calcium channel blocker (dihydropyridine) · Cardiovascular
Nifedipine is a calcium channel blocker that inhibits calcium influx into vascular smooth muscle and cardiac cells, causing vasodilation and reduced blood pressure. - Caduet · Pfizer Inc. · Dihydropyridine calcium channel blocker · Metabolic
Calcium channel antagonist inhibiting transmembrane calcium influx into vascular and cardiac muscle.
Phase 3 pipeline (2)
- Etripamil NS · Milestone Pharmaceuticals Inc. · Calcium channel blocker (non-dihydropyridine) · Cardiovascular
Etripamil is a rapid-onset, short-acting calcium channel blocker administered as a nasal spray that slows heart rate and reduces blood pressure by blocking L-type calcium channels in cardiac and vascular tissue. - Placebo of Nifedipine · Assistance Publique - Hôpitaux de Paris · calcium channel blocker · Cardiovascular
Nifedipine is a calcium channel blocker that works by relaxing blood vessels and reducing blood pressure.
Phase 2 pipeline (1)
- CM4620-IE · CalciMedica, Inc. · calcium channel blocker · Cardiovascular
CM4620-IE is a small molecule that targets the calcium channel.